Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 35, 2003 - Issue 11-12
Submit an article Journal homepage
181
Views
57
CrossRef citations to date
0
Altmetric
Original Paper

Staphylococcus aureus Bacteremia: Compliance with Standard Treatment, Long-term Outcome and Predictors of Relapse

Leonard B. Johnson St. John Hospital and Medical Center, Department of Internal Medicine, Michigan, DetroitCorrespondencee-mail. leonard. [email protected]
,
Mohammad O. Almoujahed St. John Hospital and Medical Center, Department of Internal Medicine, Michigan, Detroit
,
Karl Ilg St. John Hospital and Medical Center, Department of Internal Medicine, Michigan, Detroit
,
Layth Maolood St. John Hospital and Medical Center, Department of Internal Medicine, Michigan, Detroit
&
Riad Khatib St. John Hospital and Medical Center, Department of Internal Medicine, Michigan, Detroit
Pages 782-789 | Received 08 May 2003, Accepted 29 Jul 2003, Published online: 08 Jul 2009

Citations (57)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Hilmir Asgeirsson, Anders Thalme & Ola Weiland. (2018) Staphylococcus aureus bacteraemia and endocarditis – epidemiology and outcome: a review. Infectious Diseases 50:3, pages 175-192.
Read now
Som S Chatterjee & Michael Otto. (2013) Improved understanding of factors driving methicillin-resistant Staphylococcus aureus epidemic waves. Clinical Epidemiology 5, pages 205-217.
Read now
Riad Khatib, L. B. Johnson, M. Sharma, M. G. Fakih, R. Ganga & K. Riederer. (2009) Persistent Staphylococcus aureus bacteremia: Incidence and outcome trends over time. Scandinavian Journal of Infectious Diseases 41:1, pages 4-9.
Read now
Riad Khatib, Leonard B. Johnson, Mohamad G. Fakih, Kathleen Riederer, Amir Khosrovaneh, M Shamse Tabriz, Mamta Sharma & Sajjad Saeed. (2006) Persistence in Staphylococcus aureus bacteremia: Incidence, characteristics of patients and outcome. Scandinavian Journal of Infectious Diseases 38:1, pages 7-14.
Read now
Yardena Siegman-Igra, Prachia Reich, Ruth Orni-Wasserlauf, David Schwartz & Michael Giladi. (2005) The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia. Scandinavian Journal of Infectious Diseases 37:8, pages 572-578.
Read now

Articles from other publishers (52)

Santiago Grillo Perez, Candida Diaz-Brochero, Javier Ricardo Garzon Herazo & Oscar Mauricio Muñoz Velandia. (2024) Short-term versus usual-term antibiotic treatment for uncomplicated Staphylococcus aureus bacteremia: a systematic review and meta-analysis . Therapeutic Advances in Infectious Disease 11.
Crossref
Amy Legg, Matthew A Roberts, Jane Davies, Alan Cass, Niamh Meagher, Archana Sud, Vered Daitch, Yael Dishon Benattar, Dafna Yahav, Mical Paul, Chen Xinxin, Yeo He Ping, David Lye, Russel Lee, J Owen Robinson, Hong Foo, Adrian R Tramontana, Narin Bak, Adelaide Grenfell, Benjamin Rogers, Ying Li, Neela Joshi, Matthew O’Sullivan, Genevieve McKew, Niladri Ghosh, Kellie Schneider, Natasha E Holmes, Ravindra Dotel, Timothy Chia, Sophia Archuleta, Simon Smith, Morgyn S Warner, Christina Titin, Shirin Kalimuddin, Jason A Roberts, Steven Y C Tong, Joshua S Davis, Steven Y C Tong, David C Lye, Dafna Yahav, Archana Sud, J Owen Robinson, Jane Nelson, Sophia Archuleta, Matthew A Roberts, Alan Cass, David L Paterson, Hong Foo, Mical Paul, Stephen D Guy, Adrian R Tramontana, Genevieve B Walls, Stephen McBride, Narin Bak, Niladri Ghosh, Benjamin A Rogers, Anna P Ralph, Jane Davies, Patricia E Ferguson, Ravindra Dotel, Genevieve L McKew, Timothy J Gray, Natasha E Holmes, Simon Smith, Morgyn S Warner, Shirin Kalimuddin, Barnaby E Young, Naomi Runnegar, David N Andresen, Nicholas A Anagnostou, Sandra A Johnson, Mark D Chatfield, Allen C Cheng, Vance G FowlerJrJr, Benjamin P Howden, Niamh Meagher, David J Price, Sebastiaan J van Hal, Satinder Gill, Alexander Rofe, Matthew O'Sullivan & Joshua S Davis. (2023) Longer-term Mortality and Kidney Outcomes of Participants in the Combination Antibiotics for Methicillin-Resistant Staphylococcus aureus (CAMERA2) Trial: A Post Hoc Analysis . Open Forum Infectious Diseases 10:7.
Crossref
Ching-Yen Tsai, Chen-Hsiang Lee & I-Ling Chen. (2021) Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infectious Diseases 21:1.
Crossref
Sarah M. Schneider, Mattias Schaeg, Barbara C. Gärtner, Fabian K. Berger & Sören L. Becker. (2020) Do written diagnosis-treatment recommendations on microbiological test reports improve the management of Staphylococcus aureus bacteremia? A single-center, retrospective, observational study. Diagnostic Microbiology and Infectious Disease 98:4, pages 115170.
Crossref
Walter N. Harrington, Jacqueline Nolan, Dmitry A. Nedosekin, Mark S. Smeltzer & Vladimir P. Zharov. (2019) Real‐Time Monitoring of Bacteria Clearance From Blood in a Murine Model. Cytometry Part A 97:7, pages 706-712.
Crossref
Colum P. Dunne, Phelim Ryan, Roisin Connolly, Suzanne S. Dunne, Mohammed A. Kaballo, James Powell, Bernie Woulfe, Nuala H. O'Connell & Rajnish K. Gupta. (2020) Management of Staphylococcus aureus bacteraemia (SAB) in the oncology patient: Further evidence supports prompt removal of central venous catheters and shorter duration of intravenous antimicrobial therapy. Infection Prevention in Practice 2:1, pages 100037.
Crossref
Melicent Peck, Michael E. Rothenberg, Rong Deng, Nicholas Lewin-Koh, Gaohong She, Amrita V. Kamath, Montserrat Carrasco-Triguero, Ola Saad, Aide Castro, Lisa Teufel, Daniel S. Dickerson, Marisa Leonardelli & Jorge A. Tavel. (2019) A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti- Staphylococcus aureus Thiomab Antibody-Antibiotic Conjugate, in Healthy Volunteers . Antimicrobial Agents and Chemotherapy 63:6.
Crossref
Achim J Kaasch, Winfried V Kern, Insa Joost, Martin Hellmich, Harald Seifert & Siegbert Rieg. (2019) Effect of Clinically Uninfected Orthopedic Implants and Pacemakers/AICDs in Low-Risk Staphylococcus aureus Bloodstream Infection on Crude Mortality Rate: A Post Hoc Analysis of a Large Cohort Study. Open Forum Infectious Diseases 6:5.
Crossref
John C Lam, Daniel B Gregson, Stephen Robinson, Ranjani Somayaji, Lisa Welikovitch, John M Conly & Michael D Parkins. (2019) Infectious diseases consultation improves key performance metrics in the management of Staphylococcus aureus bacteremia: A multicentre cohort study . Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 4:1, pages 24-32.
Crossref
K. Bolhuis, L. J. Bakker, J. T. Keijer & P. J. de Vries. (2018) Implementing a hospital-wide protocol for Staphylococcus aureus bacteremia. European Journal of Clinical Microbiology & Infectious Diseases 37:8, pages 1553-1562.
Crossref
Joshua S. Everhart, Joel L. Mayerson, Andrew H. Glassman, Jonathan D. Barlow, Julie Y. Bishop & Thomas J. Scharschmidt. (2018) Prior staphylococcal bacteremia and risk of surgical site infection after total joint arthroplasty: a nested case-control study. Current Orthopaedic Practice 29:1, pages 25-30.
Crossref
Tomi Mölkänen, Eeva Ruotsalainen, Esa M. Rintala & Asko Järvinen. (2016) Predictive Value of C-Reactive Protein (CRP) in Identifying Fatal Outcome and Deep Infections in Staphylococcus aureus Bacteremia. PLOS ONE 11:5, pages e0155644.
Crossref
Sophie M. Lehar, Thomas Pillow, Min Xu, Leanna Staben, Kimberly K. Kajihara, Richard Vandlen, Laura DePalatis, Helga Raab, Wouter L. Hazenbos, J. Hiroshi Morisaki, Janice Kim, Summer Park, Martine Darwish, Byoung-Chul Lee, Hilda Hernandez, Kelly M. Loyet, Patrick Lupardus, Rina Fong, Donghong Yan, Cecile Chalouni, Elizabeth Luis, Yana Khalfin, Emile Plise, Jonathan Cheong, Joseph P. Lyssikatos, Magnus Strandh, Klaus Koefoed, Peter S. Andersen, John A. Flygare, Man Wah Tan, Eric J. Brown & Sanjeev Mariathasan. (2015) Novel antibody–antibiotic conjugate eliminates intracellular S. aureus. Nature 527:7578, pages 323-328.
Crossref
Justin Albertson, Jennifer S. McDanel, Ryan Carnahan, Elizabeth Chrischilles, Eli N. Perencevich, Michihiko Goto, Lan Jiang, Bruce Alexander & Marin L. Schweizer. (2015) Determination of Risk Factors for Recurrent Methicillin-Resistant Staphylococcus aureus Bacteremia in a Veterans Affairs Healthcare System Population . Infection Control & Hospital Epidemiology 36:5, pages 543-549.
Crossref
Anas Saleh, Ashish Khanna, Kevin M. Chagin, Alison K. Klika, Douglas Johnston & Wael K. Barsoum. (2015) Glycopeptides Versus β-Lactams for the Prevention of Surgical Site Infections in Cardiovascular and Orthopedic Surgery. Annals of Surgery 261:1, pages 72-80.
Crossref
Vladimir KrcméryNoha EI SakkaIan M Gould. 2013. Microbial Drug Resistance. Microbial Drug Resistance 6 20 .
Jabeen Noore, Adly Noore & Bingyun Li. (2013) Cationic Antimicrobial Peptide LL-37 Is Effective against both Extra- and Intracellular Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 57:3, pages 1283-1290.
Crossref
Yong Pil Chong, Song Mi Moon, Kyung-Mi Bang, Hyun Jung Park, So-Youn Park, Mi-Na Kim, Ki-Ho Park, Sung-Han Kim, Sang-Oh Lee, Sang-Ho Choi, Jin-Yong Jeong, Jun Hee Woo & Yang Soo Kim. (2013) Treatment Duration for Uncomplicated Staphylococcus aureus Bacteremia To Prevent Relapse: Analysis of a Prospective Observational Cohort Study. Antimicrobial Agents and Chemotherapy 57:3, pages 1150-1156.
Crossref
Chen-Hsiang Lee, Chun-Chih Chien & Jien-Wei Liu. (2013) Timing of Initiating Glycopeptide Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: The Impact on Clinical Outcome . The Scientific World Journal 2013, pages 1-7.
Crossref
Ann L. Bull, Leon J. Worth & Michael J. Richards. (2012) Impact of Vancomycin Surgical Antibiotic Prophylaxis on the Development of Methicillin-Sensitive Staphylococcus aureus Surgical Site Infections. Annals of Surgery 256:6, pages 1089-1092.
Crossref
Simon W. Lam, Seth R. Bauer & Elizabeth A. Neuner. (2012) Predictors of septic shock in patients with methicillin-resistant Staphylococcus aureus bacteremia. International Journal of Infectious Diseases 16:6, pages e453-e456.
Crossref
T. L. Lemonovich, K. Haynes, E. Lautenbach & V. K. Amorosa. (2011) Combination therapy with an aminoglycoside for Staphylococcus aureus endocarditis and/or persistent bacteremia is associated with a decreased rate of recurrent bacteremia: a cohort study. Infection 39:6, pages 549-554.
Crossref
Allen C Cheng, Michelle Yong, Eugene Athan & Vance Fowler. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Hilmir Asgeirsson, Mar Kristjansson, Karl G. Kristinsson & Olafur Gudlaugsson. (2011) Staphylococcus aureus bacteraemia – Nationwide assessment of treatment adequacy and outcome. Journal of Infection 62:5, pages 339-346.
Crossref
Anne Sandberg, Sandrine Lemaire, Françoise Van Bambeke, Paul M. Tulkens, Diarmaid Hughes, Christof von Eiff & Niels Frimodt-Møller. (2011) Intra- and Extracellular Activities of Dicloxacillin and Linezolid against a Clinical Staphylococcus aureus Strain with a Small-Colony-Variant Phenotype in an In Vitro Model of THP-1 Macrophages and an In Vivo Mouse Peritonitis Model . Antimicrobial Agents and Chemotherapy 55:4, pages 1443-1452.
Crossref
Guy E Thwaites, Jonathan D Edgeworth, Effrossyni Gkrania-Klotsas, Andrew Kirby, Robert Tilley, M Estée Török, Sarah Walker, Heiman FL Wertheim, Peter Wilson & Martin J Llewelyn. (2011) Clinical management of Staphylococcus aureus bacteraemia. The Lancet Infectious Diseases 11:3, pages 208-222.
Crossref
Clayton Harro, Robert Betts, Walter Orenstein, Eun-Jeong Kwak, Howard E. Greenberg, Matthew T. Onorato, Jon Hartzel, Joy Lipka, Mark J. DiNubile & Nicholas Kartsonis. (2010) Safety and Immunogenicity of a Novel Staphylococcus aureus Vaccine: Results from the First Study of the Vaccine Dose Range in Humans . Clinical and Vaccine Immunology 17:12, pages 1868-1874.
Crossref
Jutta Berger, Magda Diab-Elschahawi, Alexander Blacky, Elisabeth Pernicka, Verena Spertini, Ojan Assadian, Walter Koller & Karl J. Aichberger. (2010) A matched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: Extended perspectives beyond resistance. American Journal of Infection Control 38:10, pages 839-845.
Crossref
Wen-Chi Huang, Chen-Hsiang Lee & Jien-Wei Liu. (2010) Clinical Characteristics and Risk Factors for Mortality in Patients with Meningitis Caused by Staphylococcus aureus and Vancomycin Minimal Inhibitory Concentrations Against These Isolates. Journal of Microbiology, Immunology and Infection 43:6, pages 470-477.
Crossref
F. Hanses, C. Spaeth, B. P. Ehrenstein, H.-J. Linde, J. Schölmerich & B. Salzberger. (2010) Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia. Infection 38:6, pages 465-470.
Crossref
Elizabeth A. Neuner, Ed Casabar, Richard Reichley & Peggy S. McKinnon. (2010) Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia. Diagnostic Microbiology and Infectious Disease 67:3, pages 228-233.
Crossref
Anne Sandberg, Klaus Skovbo Jensen, Pierre Baudoux, Françoise Van Bambeke, Paul M. Tulkens & Niels Frimodt-Møller. (2010) Intra- and Extracellular Activities of Dicloxacillin against Staphylococcus aureus In Vivo and In Vitro . Antimicrobial Agents and Chemotherapy 54:6, pages 2391-2400.
Crossref
A. Sandberg, K. S. Jensen, P. Baudoux, F. Van Bambeke, P. M. Tulkens & N. Frimodt-Moller. (2010) Intra- and extracellular activity of linezolid against Staphylococcus aureus in vivo and in vitro. Journal of Antimicrobial Chemotherapy 65:5, pages 962-973.
Crossref
Jonas Marschall, Joshua Doherty & David K. Warren. (2010) The epidemiology of recurrent Gram-negative bacteremia in a tertiary-care hospital. Diagnostic Microbiology and Infectious Disease 66:4, pages 456-459.
Crossref
Siegbert Rieg, Gabriele Peyerl-Hoffmann, Katja de With, Christian Theilacker, Dirk Wagner, Johannes Hübner, Markus Dettenkofer, Achim Kaasch, Harald Seifert, Christian Schneider & Winfried V. Kern. (2009) Mortality of S. aureus bacteremia and infectious diseases specialist consultation – A study of 521 patients in Germany. Journal of Infection 59:4, pages 232-239.
Crossref
Timothy M. Walker, Ian C.J.W. Bowler & Philip Bejon. (2009) Risk factors for recurrence after Staphylococcus aureus bacteraemia. A retrospective matched case–control study. Journal of Infection 58:6, pages 411-416.
Crossref
Anne Sandberg, Jonas H. R. Hessler, Robert L. Skov, Jens Blom & Niels Frimodt-Møller. (2009) Intracellular Activity of Antibiotics against Staphylococcus aureus in a Mouse Peritonitis Model . Antimicrobial Agents and Chemotherapy 53:5, pages 1874-1883.
Crossref
F. K. Gould, R. Brindle, P. R. Chadwick, A. P. Fraise, S. Hill, D. Nathwani, G. L. Ridgway, M. J. Spry & R. E. Warren. (2009) Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. Journal of Antimicrobial Chemotherapy 63:5, pages 849-861.
Crossref
Allen C Cheng, Michelle Yong, Eugene Athan & Vance Fowler. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Dave M. Lutomski, Jennifer A. LaFollette, Michael A. Biaglow & Lisa A. Haglund. (2012) Antibiotic Allergies in the Medical Record: Effect on Drug Selection and Assessment of Validity. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28:11, pages 1348-1353.
Crossref
G. Jacobsson, E. Gustafsson & R. Andersson. (2008) Outcome for invasive Staphylococcus aureus infections. European Journal of Clinical Microbiology & Infectious Diseases 27:9, pages 839-848.
Crossref
P. Lillie, P. Moss, H. Thaker, M. Parsonage, K. Adams, J. Meigh, R. Meigh, S. Mawer, W. Dibb, J. Wilson, S. Musaad, P. O'Brien & G. Barlow. (2008) Development, impact and outcomes of the Hull Bacteraemia Service. QJM 101:11, pages 889-898.
Crossref
E. J. C. Goldstein & R. A. Proctor. (2008) Role of Folate Antagonists in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection. Clinical Infectious Diseases 46:4, pages 584-593.
Crossref
Kristen Kreisel, Kristina Boyd, Patricia Langenberg & Mary-Claire Roghmann. (2006) Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia. Diagnostic Microbiology and Infectious Disease 55:3, pages 179-184.
Crossref
Curtis G. Gemmell, David I. Edwards, Adam P. Fraise, F. Kate Gould, Geoff L. Ridgway & Rod E. Warren. (2006) Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. Journal of Antimicrobial Chemotherapy 57:4, pages 589-608.
Crossref
R. Khatib, S. Saeed, M. Sharma, K. Riederer, M. G. Fakih & L. B. Johnson. (2006) Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. European Journal of Clinical Microbiology & Infectious Diseases 25:3, pages 181-185.
Crossref
E. RUOTSALAINEN, A. JÄRVINEN, I. KOIVULA, H. KAUMA, E. RINTALA, J. LUMIO, P. KOTILAINEN, M. VAARA, J. NIKOSKELAINEN & V. VALTONEN. (2005) Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients . Journal of Internal Medicine 259:2, pages 179-190.
Crossref
Niklas Palmqvist, Gregg J. Silverman, Elisabet Josefsson & Andrzej Tarkowski. (2005) Bacterial cell wall-expressed protein A triggers supraclonal B-cell responses upon in vivo infection with Staphylococcus aureus. Microbes and Infection 7:15, pages 1501-1511.
Crossref
Andrew F. Shorr, Mark J. Kunkel & Marin Kollef. (2005) Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies. Journal of Antimicrobial Chemotherapy 56:5, pages 923-929.
Crossref
R. Khatib, K. Riederer, S. Saeed, L. B. Johnson, M. G. Fakih, M. Sharma, M. S. Tabriz & A. Khosrovaneh. (2005) Time to Positivity in Staphylococcus aureus Bacteremia: Possible Correlation with the Source and Outcome of Infection. Clinical Infectious Diseases 41:5, pages 594-598.
Crossref
Peter CollignonGraeme R. NimmoThomas GottliebIain B. Gosbell. (2005) Staphylococcus aureus Bacteremia, Australia . Emerging Infectious Diseases 11:4, pages 554-561.
Crossref
D. A. R. Watson. (2004) The long and short of the risk of antibiotic treatment failure. Internal Medicine Journal 34:7, pages 379-382.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.